Pliant Therapeutics Inc (PLRX)
14.88
+0.33
(+2.27%)
USD |
NASDAQ |
Mar 28, 16:00
14.89
+0.01
(+0.07%)
After-Hours: 20:00
Pliant Therapeutics Cash from Financing (Quarterly): 0.219M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.219M |
September 30, 2023 | 0.699M |
June 30, 2023 | 0.161M |
March 31, 2023 | 273.33M |
December 31, 2022 | 0.284M |
September 30, 2022 | 216.30M |
June 30, 2022 | 10.43M |
March 31, 2022 | -0.153M |
December 31, 2021 | 0.516M |
September 30, 2021 | 0.449M |
Date | Value |
---|---|
June 30, 2021 | 0.192M |
March 31, 2021 | 1.37M |
December 31, 2020 | 0.237M |
September 30, 2020 | -2.365M |
June 30, 2020 | 163.64M |
March 31, 2020 | 51.70M |
December 31, 2019 | 46.83M |
September 30, 2019 | -0.394M |
June 30, 2019 | -0.771M |
March 31, 2019 | -0.127M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.365M
Minimum
Sep 2020
273.33M
Maximum
Mar 2023
38.13M
Average
0.3665M
Median
Cash from Financing (Quarterly) Benchmarks
Masimo Corp | -36.30M |
Liquidia Corp | 23.64M |
Vor Biopharma Inc | 0.025M |
CEL-SCI Corp | 4.048M |
AIM ImmunoTech Inc | 0.233M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -25.10M |
Cash from Investing (Quarterly) | 31.92M |
Free Cash Flow | -117.28M |
Free Cash Flow Per Share (Quarterly) | -0.42 |
Free Cash Flow Yield | -13.43% |